This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Inconclusive Evidence for the Efficacy of Olanzapine in the Treatment of Negative Symptoms in Schizophrenia

Brendan P. Murphy, FRANZCP, MRCPsych

Published: January 15, 2008

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: In a recent systematic review of the pharmacologictreatment of primary negative symptoms in schizophrenia, mycolleagues and I1 concluded that there was a paucity of evidenceregarding efficacy of treatments of primary negative symptomsand that the lack of standardized research designs had ledto marked inconsistencies in results. A case in point wasolanzapine’s efficacy against primary negative symptoms. Ofthe 4 conducted trials, the only study to use selected patientswith primary negative symptoms found no benefit2; 2 studiesusing path analysis suggested the reverse,3,4 while a third wasambivalent.5‘ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 69

Quick Links: